Nippon India Pharma Fund-Growth Plan-Growth Option

(Erstwhile Reliance Pharma Fund-Growth Plan-Growth Option)
Fund House: Nippon India Mutual Fund
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 01-06-2004
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 1.94% As on (31-10-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 4,785.53 Cr As on (31-10-2022)
Turn over: 24% | Exit Load: 1% for redemption within 30 days

291.894

20.0%

PERFORMANCE

Returns Type:
of  
Start :  
End : 
Period:  
This Scheme
-
vs
NIFTY 50 TRI
-
Gold
-
PPF
-
Returns Type:
of  
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
1 Years 8 Months
5 Years 6 Months
6 Years 0 Months
10 Years 1 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Current Asset Allocation (%)

Indicators

Volatility 15.77
Sharp Ratio 1.0
Alpha 3.1
Beta 0.93
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date
1 Year
Return(%)
2 Year
Return(%)
3 Year
Return(%)
5 Year
Return(%)
10 Year
Return(%)
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -3.15 10.08 24.49 16.59 15.6
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 2.38 10.42 24.36 12.59 14.55
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 0.21 10.64 28.14 - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -1.05 8.76 24.28 - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -1.21 9.43 22.77 14.92 -
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 -1.68 - - - -
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -4.66 10.82 26.75 - -
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -5.56 6.74 18.89 - -
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -5.68 6.55 21.94 12.41 12.64
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -6.29 4.12 18.08 - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

21.26%

Others

2.07%

Large Cap

48.27%

Mid Cap

28.4%

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback
Notification